Itai Tzchori
About Itai Tzchori
Itai Tzchori is the Head of Animal Studies at Novocure in Haifa, Israel, with extensive experience in R&D leadership roles across multiple companies in Israel.
Current Role at Novocure
Itai Tzchori currently serves as the Head of Animal Studies at Novocure in Haifa, Israel. He joined Novocure in February 2021, bringing with him extensive experience in research and development leadership. In this role, he oversees animal studies which are crucial for the company's innovative therapeutic solutions.
Experience as Acting CEO at OBVISLIM
From 2018 to 2021, Itai Tzchori served as the Acting CEO of OBVISLIM in Kfar Baruch, Emek Yizrael. During his tenure, he led the company for three years, guiding it through strategic developments and operational advancements.
R&D Leadership Roles at SuperMeat and Orgenesis Ltd
Itai Tzchori held significant R&D positions at both SuperMeat and Orgenesis Ltd. At SuperMeat, he was the Head of R&D from 2017 to 2018, focusing on cutting-edge food technologies. Prior to that, he worked as a Development Manager at Orgenesis Ltd from 2016 to 2017, playing a key role in managing important development projects.
Director of New Technologies at MGVS
Between 2010 and 2013, Itai Tzchori was the Director of New Technologies at MGVS. In this capacity, he was responsible for driving innovation and leading new technology initiatives within the company. His contributions helped in shaping the company's technological advancements.
Academic and Research Background
Itai Tzchori has a strong academic and research background. He served as a faculty member in Medical Bioengineering at Technion - Israel Institute of Technology from 2008 to 2010. Additionally, he conducted research at the National Institutes of Health in the NICHD division from 2003 to 2008. Tzchori holds a Ph.D. in Endocrinology from Tel Aviv University, attained between 1999 and 2003.